Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab von Iida, Mari, Bahrar, Harsh, Brand, Toni M, Pearson, Hannah E, Coan, John P, Orbuch, Rachel A, Flanigan, Bailey G, Swick, Adam D, Prabakaran, Prashanth J, Lantto, Johan, Horak, Ivan D, Kragh, Michael, Salgia, Ravi, Kimple, Randy J, Wheeler, Deric L

Volltext

Outcomes for patients with head and neck squamous cell carcinoma presenting with N3 nodal disease von Witek, Matthew E, Wieland, Aaron M, Chen, Shuai, Kennedy, Tabassum A, Hullett, Craig R, Liang, Evan, Hartig, Gregory K, Kimple, Randy J, Harari, Paul M

Volltext

Abstract A128: AXL mediates cetuximab resistance through tyrosine 821 and activation of c-Abl kinase in head and neck cancer von McDaniel, Nellie K, Iida, Mari, Nickel, Kwangok P, Rodems, Tamara S, Swick, Adam D, Prabakaran, Prashanth J, Eckers-Kubatzke, Jaimee C, Welke, Noah B, Kranjac, Carlene, Schulz, Alison E, Kimple, Randy J, Salgia, Ravi, Wheeler, Deric L

Volltext

Abstract 5898: The consomic xenograft model identifies genetic changes in the tumor microenvironment that alter the growth and metastasis of head and neck cancers von Straza, Michael W., Rymaszewski, Amy, Nickel, Kwangok P., Frei, Anne, Chatterjee, Anirban, Schlaak, Rachel, Joshi, Amit, Flister, Michael, Kimple, Randy J., Bergom, Carmen

Volltext